NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024
NEXGEL (NASDAQ: NXGL), a provider of medical and OTC products specializing in ultra-gentle, high-water-content hydrogels, has announced its participation in the upcoming iAccess Alpha Virtual Best Ideas Winter Conference 2024.
Chief Executive Officer Adam Levy will deliver a presentation on Tuesday, December 10th at 10:30 a.m. ET. The two-day conference will take place on December 10-11, 2024. Interested parties can access the webcast presentation through the provided link, and one-on-one investor meetings can be arranged through iAccess representatives or KCSA Strategic Communications.
NEXGEL (NASDAQ: NXGL), un fornitore di prodotti medici e OTC specializzato in idrogeli ultra-delicati ad alto contenuto d'acqua, ha annunciato la sua partecipazione alla prossima iAccess Alpha Virtual Best Ideas Winter Conference 2024.
Il Chief Executive Officer Adam Levy presenterà un'intervento il martedì 10 dicembre alle 10:30 a.m. ET. La conferenza di due giorni si svolgerà dal 10 all'11 dicembre 2024. Le parti interessate possono accedere alla presentazione in webcast tramite il link fornito e possono essere organizzati incontri individuali con gli investitori attraverso i rappresentanti di iAccess o KCSA Strategic Communications.
NEXGEL (NASDAQ: NXGL), un proveedor de productos médicos y OTC que se especializa en hidrogeles ultra-suaves de alto contenido acuoso, ha anunciado su participación en la próxima iAccess Alpha Virtual Best Ideas Winter Conference 2024.
El Director Ejecutivo Adam Levy ofrecerá una presentación el martes 10 de diciembre a las 10:30 a.m. ET. La conferencia de dos días se llevará a cabo del 10 al 11 de diciembre de 2024. Las partes interesadas pueden acceder a la presentación por webcast a través del enlace proporcionado, y se pueden organizar reuniones individuales con inversores a través de representantes de iAccess o KCSA Strategic Communications.
NEXGEL (NASDAQ: NXGL)은 초부드럽고 높은 수분 함량의 하이드로겔을 전문으로 하는 의료 및 OTC 제품 공급업체로, 다가오는 iAccess Alpha Virtual Best Ideas Winter Conference 2024에 참여할 것이라고 발표했습니다.
CEO 아담 레비는 2024년 12월 10일 화요일 오전 10시 30분 ET에 발표를 진행할 예정입니다. 이틀간의 회의는 2024년 12월 10일부터 11일 사이에 열립니다. 관심 있는 분들은 제공된 링크를 통해 웹캐스트 발표에 접속할 수 있으며, iAccess 대표자나 KCSA Strategic Communications를 통해 1:1 투자자 미팅을 조율할 수 있습니다.
NEXGEL (NASDAQ: NXGL), un fournisseur de produits médicaux et OTC spécialisé dans les hydrogels ultra-doux et à fort contenu en eau, a annoncé sa participation à la prochaine iAccess Alpha Virtual Best Ideas Winter Conference 2024.
Le Directeur Général Adam Levy présentera une intervention le mardi 10 décembre à 10h30 ET. La conférence de deux jours se déroulera du 10 au 11 décembre 2024. Les parties intéressées peuvent accéder à la présentation en webcast via le lien fourni, et des réunions individuelles avec les investisseurs peuvent être arrangées via les représentants d’iAccess ou KCSA Strategic Communications.
NEXGEL (NASDAQ: NXGL), ein Anbieter von medizinischen und OTC-Produkten, die auf ultr sanfte, hochwasserhaltige Hydrogele spezialisiert sind, hat seine Teilnahme an der bevorstehenden iAccess Alpha Virtual Best Ideas Winter Conference 2024 angekündigt.
Der CEO Adam Levy wird am Dienstag, den 10. Dezember um 10:30 Uhr ET eine Präsentation halten. Die zweitägige Konferenz findet vom 10. bis 11. Dezember 2024 statt. Interessierte Parteien können über den bereitgestellten Link auf die Webcast-Präsentation zugreifen, und persönliche Investorenmeetings können über iAccess-Vertreter oder KCSA Strategic Communications organisiert werden.
- None.
- None.
LANGHORNE, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 and 11, 2024.
iAccess Alpha Virtual Conference Details:
Date: December 10-11, 2024
Presentation Day and Time: Tuesday, December 10th at 10:30 a.m. ET
Webcast: https://www.webcaster4.com/Webcast/Page/3074/51540
To schedule a one-on-one investor meeting with Mr. Levy, please contact your representatives at iAccess or email KCSA Strategic Communications at NEXGEL@KCSA.Com.
About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
NEXGEL@KCSA.com
FAQ
When is NEXGEL (NXGL) presenting at the iAccess Alpha Winter Conference 2024?
How can investors schedule meetings with NEXGEL (NXGL) at the iAccess conference?
What products does NEXGEL (NXGL) specialize in?
Where can I watch NEXGEL's (NXGL) presentation at the iAccess conference?
